These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. Delaney JA; Opatrny L; Brophy JM; Suissa S CMAJ; 2007 Aug; 177(4):347-51. PubMed ID: 17698822 [TBL] [Abstract][Full Text] [Related]
4. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Bhatt DL; Scheiman J; Abraham NS; Antman EM; Chan FK; Furberg CD; Johnson DA; Mahaffey KW; Quigley EM; Harrington RA; Bates ER; Bridges CR; Eisenberg MJ; Ferrari VA; Hlatky MA; Kaul S; Lindner JR; Moliterno DJ; Mukherjee D; Schofield RS; Rosenson RS; Stein JH; Weitz HH; Wesley DJ; J Am Coll Cardiol; 2008 Oct; 52(18):1502-17. PubMed ID: 19017521 [No Abstract] [Full Text] [Related]
5. [No indication of a higher risk of severe gastrointestinal hemorrhage with non-vitamin K antagonist oral anticoagulant]. Zechmann S Praxis (Bern 1994); 2016 Jan; 105(2):109-10. PubMed ID: 26787335 [No Abstract] [Full Text] [Related]
6. [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur]. Rossini R; Lucà MG; Scuri P; Invernizzi P; Strazzabosco M; Gavazzi A Ital Heart J Suppl; 2005 Oct; 6(10):621-6. PubMed ID: 16273749 [No Abstract] [Full Text] [Related]
7. Management of Antiplatelet Agents and Anticoagulants in Patients with Gastrointestinal Bleeding. Abraham NS Gastrointest Endosc Clin N Am; 2015 Jul; 25(3):449-62. PubMed ID: 26142031 [TBL] [Abstract][Full Text] [Related]
8. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Bhatt DL; Scheiman J; Abraham NS; Antman EM; Chan FK; Furberg CD; Johnson DA; Mahaffey KW; Quigley EM; Harrington RA; Bates ER; Bridges CR; Eisenberg MJ; Ferrari VA; Hlatky MA; Kaul S; Lindner JR; Moliterno DJ; Mukherjee D; Schofield RS; Rosenson RS; Stein JH; Weitz HH; Wesley DJ; ; ; Am J Gastroenterol; 2008 Nov; 103(11):2890-907. PubMed ID: 18853965 [No Abstract] [Full Text] [Related]
9. [Clinical guidelines for inhibitors of hemostasis and locoregional neuraxial anesthesia. Spanish Society of Anesthesiology-Resuscitation and Pain Therapy, Division of Hemostasis, Transfusion Medicine, and Perioperative Fluid Therapy]. Sociedad Española de Anestesiología-Reanimación y Terapéutica del Dolor, Sección de Hemostasia, Medicina Transfusional y Fluidoterapia Perioperatoria Rev Esp Anestesiol Reanim; 2005; 52(7):413-20. PubMed ID: 16200921 [No Abstract] [Full Text] [Related]
11. Combined effect of proton-pump inhibitors and other drugs with regard to lower gastrointestinal tract bleeding with special reference to low-dose aspirin. Kawada T J Gastroenterol; 2016 Feb; 51(2):173. PubMed ID: 26545370 [No Abstract] [Full Text] [Related]
12. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Veitch AM; Baglin TP; Gershlick AH; Harnden SM; Tighe R; Cairns S; ; ; Gut; 2008 Sep; 57(9):1322-9. PubMed ID: 18469092 [No Abstract] [Full Text] [Related]
13. Reply to the letter by Kawada entitled ''Combined effect of proton-pump inhibitors and other drugs with regard to lower gastrointestinal tract bleeding with special reference to low-dose aspirin''. Nagata N; Shimbo T J Gastroenterol; 2016 Feb; 51(2):174-5. PubMed ID: 26525540 [No Abstract] [Full Text] [Related]
14. [Polypharmacy, compliance and non-prescription medication in patients with cardiovascular disease in Germany]. Rottlaender D; Scherner M; Schneider T; Erdmann E Dtsch Med Wochenschr; 2007 Jan; 132(4):139-44. PubMed ID: 17230328 [TBL] [Abstract][Full Text] [Related]
15. [Aspirin and surgery]. García-Sancho Martín L An R Acad Nac Med (Madr); 1997; 114(4):771-92. PubMed ID: 9616943 [No Abstract] [Full Text] [Related]
16. [Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy]. Morini S; Zullo A G Ital Cardiol (Rome); 2010 Jun; 11(6):488-92; discussion 492. PubMed ID: 20922875 [No Abstract] [Full Text] [Related]
17. Surgical workload, risk factors and complications in patients on warfarin with gastrointestinal bleeding. Som R; Gossage JA; Crane A; Rowe PH Int J Surg; 2010; 8(1):52-5. PubMed ID: 19883802 [TBL] [Abstract][Full Text] [Related]
18. Clinical practice guidelines for managing coagulation in patients undergoing endoscopic procedures. Parras FA Rev Esp Enferm Dig; 2010 Feb; 102(2):124-38. PubMed ID: 20361848 [No Abstract] [Full Text] [Related]
19. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy. Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O Aliment Pharmacol Ther; 2006 Feb; 23(4):489-95. PubMed ID: 16441469 [TBL] [Abstract][Full Text] [Related]